Merck KGaA CFO Helene von Roeder discusses the group's third-quarter earnings and its progress with drug trials.

Merck , known as MSD outside of the United States and Canada, and LaNova Medicines Ltd. (LaNova), a privately held clinical-stage biotechnology company, today announced that Merck has entered into an ...

Each year, 500 to 1,000 people in the U.S. are diagnosed with pulmonary arterial hypertension (PAH), a progressive and often under-detected disease. To address the significant impact of this disease ...

US stock futures edged higher Thursday ahead of a highly-anticipated speech by Fed chair Jerome Powell, which could provide ...

It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector ...

Here's why the Vanguard Utilities ETF (NYSEMKT: VPU), Vanguard Consumer Staples ETF (NYSEMKT: VDC), and Vanguard Health Care ...

I’ve probably [examined] over 1000 patients suspecting of it ... the vertical of the bridge. For example, Merck [& Co.] has ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

Alphabet's Q3 results show strong revenue and operating income growth, but declining free cash flow. Read why I think GOOG ...

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

Shipping giant CMA CGM has asked its customers to be ready with the additional mandatory data required to be provided under the European Unions’ Import Control System 2 (ICS2) regulations, to ...

For comparison, only 72% of the stocks in the Russell 1000 Value Index, this fund’s large-value category benchmark, paid dividends. The FTSE High Dividend Yield Index has 450 stocks, and true to ...